Celularity Inc. (NASDAQ: CELU)
$2.7050
-0.1450 ( -4.75% ) 43.7K
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.
Market Data
Open
$2.7050
Previous close
$2.8500
Volume
43.7K
Market cap
$57.21M
Day range
$2.6110 - $2.8800
52 week range
$1.3000 - $7.9700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 4 | Nov 19, 2024 |
nt | Quarterly Reports | 1 | Nov 15, 2024 |
8-k | 8K-related | 14 | Nov 08, 2024 |
8-k | 8K-related | 15 | Nov 07, 2024 |
10-q | Quarterly Reports | 95 | Nov 07, 2024 |
8-k | 8K-related | 15 | Oct 25, 2024 |
8-k | 8K-related | 14 | Oct 21, 2024 |
8-k | 8K-related | 15 | Oct 16, 2024 |
10-q | Quarterly Reports | 96 | Oct 16, 2024 |
8-k | 8K-related | 14 | Sep 13, 2024 |